Adrian Spillmann has been the Head of Corporate Intellectual Property for the Valneva group in Vienna, Austria, since 2010 and specializes in patent and trademark prosecution, patent and trademark enforcement, patent drafting, patent portfolio management, in house patent counseling, patent monetization and intellectual property transactions in biotechnology and pharmaceuticals and other life science projects. He is also involved in the monetization of various research projects. His areas of expertise include protection of prophylactics, therapeutics and diagnostics for infectious diseases, immunological disorders, cancerous diseases, neurodegenerative disorders and metabolic disorders, vaccine technologies, antibody technologies, production of biological and chemical compounds, new medical uses and formulations of known compounds. After earning his Ph.D. at the University of Zurich, Switzerland, Adrian was a Consultant at Deloitte, followed by a 7 years stay in various positions in the patent department at Novartis. Furthermore, Adrian was Senior Patent Attorney at Ablynx, an antibody company in Belgium, for 3 years. Adrian is European and Swiss registered patent attorney and received his LLM from the University of Law in London.